Search for: "Anda Pharmaceuticals, Inc"
Results 221 - 240
of 605
Sorted by Relevance
|
Sort by Date
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
27 Feb 2011, 8:59 pm
Mylan Inc. et al. 1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S. [read post]
30 Sep 2013, 8:12 am
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
8 Jul 2012, 9:13 pm
Roxane Laboratories, Inc. et al. 2:12-cv-00593; filed July 3, 2012 in the Southern District of Ohio • Plaintiffs: Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; P.F. [read post]
22 Oct 2013, 2:28 pm
Inc., et al., C.A. [read post]
20 Sep 2007, 10:05 pm
Lupin, Ltd. and Lupin Pharmaceuticals, Inc., No. 07, Civ. 0632 (D. [read post]
20 Aug 2009, 12:52 am
Following a bench trial concerning Merck's Singulair ® patent, the court rejected Teva Pharmaceutical's validity and unenforceability defenses and concluded that Teva's ANDA applications infringed the patent-in-suit. [read post]
14 Jun 2011, 9:24 pm
• Defendants: Mylan Inc.; Mylan Pharmaceuticals, Inc. [read post]
29 Apr 2013, 2:53 pm
Zydus Pharmaceuticals (USA) Inc., et al., C.A. [read post]
10 Feb 2017, 10:52 am
Andrews in Endo Pharmaceuticals Inc. et al. v. [read post]
14 Jun 2010, 6:12 pm
Par Pharmaceutical filed an ANDA to make a time-released version of the opiate tramadol. [read post]
3 Jun 2013, 8:59 am
Roxane Laboratories, Inc., C.A. [read post]
12 Sep 2012, 6:14 pm
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
7 Jul 2020, 6:04 am
A Paragraph IV certification is an ANDA filer’s statement that it intends to market its bioequivalent pharmaceutical product before the expiration of a patent listed as covering that product because the ANDA filer believes such patent is either not infringed or invalid. [read post]
15 Feb 2013, 9:29 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
13 May 2010, 9:59 pm
By James DeGiulio -- Medicis Settles Solodyn Infringement Case with Ranbaxy Medicis Pharmaceutical Corp. has reached consent and licensing agreements with Ranbaxy Laboratories Inc., thus settling patent infringement claims against Ranbaxy over Medicis' oral acne drug Solodyn. [read post]
15 Jun 2014, 8:46 pm
.; Glenmark Generics Inc., USA • Defendant: Ferring, B.V. [read post]
12 Jan 2014, 6:36 pm
.; Micro Labs USA Inc. [read post]
31 Jul 2014, 8:43 pm
Cubist Pharmaceuticals Inc. v. [read post]
